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be eliminated for purposes of regulation or quality con-Cecile M. Pickart*
trol. This problem is solved by proteases, which oftenDepartment of Biochemistry and Molecular Biology
use a combination of acid, base, and nucleophilic cataly-Bloomberg School of Public Health
sis to facilitate the attack of water on peptide bonds.Johns Hopkins University
Proteases are rarely energy-dependent, however, be-Baltimore, Maryland 21205
cause the reaction that they catalyze is thermodynami-
cally favorable.
The discovery of the ubiquitin/proteasome pathwayTwo papers published in 1984 by the Varshavsky labo-
emerged from efforts to understand why intracellularratory revealed that the ubiquitin/proteasome pathway
proteolysis, measured as the release of amino acidsis the principal system for degradation of short-lived
from intact cells, requires metabolic energy (Simpson,proteins in mammalian cells, setting the stage for fu-
1953). Key elements of the answer became clear in theture demonstrations of this pathway’s many regulatory
early 1980’s as a result of the pioneering biochemicalroles. This perspective discusses the impact of those
studies of Hershko and coworkers. These investigatorspapers and highlights some of the subsequent insights
found that energy, in the form of ATP, is needed tothat have led to our current appreciation of the breadth
modify proteolytic substrates with ubiquitin, a highlyof ubiquitin-mediated signaling.
conserved 76 amino acid polypeptide that is joined to
a substrate lysine side chain through an isopeptide bond
to ubiquitin’s C terminus (Ciechanover et al., 1980; HershkoIntroduction
et al., 1980). Ubiquitination occurs through sequentialOver a thousand papers published in the year 2003 alone
steps catalyzed by activating (E1), conjugating (E2), andcited “ubiquitin” as a keyword, compared to fewer than
ligase (E3) enzymes (Hershko et al., 1983). The presencea hundred such papers in 1984. The dramatic difference
of multiple substrate-linked ubiquitins recruits the 26Sreflects the efforts of many laboratories, whose collec-
proteasome, a 2.5 MDa complex that uses energy de-tive findings have shown that nearly every aspect of
rived from ATP hydrolysis to unfold the substrate poly-eukaryotic cell biology carries a connection to ubiquitin.
peptide chain and translocate it into an interior chamberAs a result, today it is easy to frame a career around
(Baumeister et al., 1998). Having arrived at this site, thethis remarkable signaling molecule. But one’s motives
substrate is hydrolyzed by a nucleophilic mechanism tohad to be purer in 1984—despite the novelty of ubiqui-
produce small peptides. Ubiquitin is spared from degra-tin’s role as a degradation signal, it was impossible to
dation through its release from the substrate (or a sub-gauge the generality and significance of the eponymous
strate fragment) by deubiquitinating enzymes (Hershkoproteolytic pathway.
et al., 1980). Thus, there are two independent reasonsIn the accompanying supplement, Cell republishes
why ATP is required for intracellular proteolysis: to acti-two seminal papers that provided major insights into
vate ubiquitin’s C terminus in preparation for conjugationwhat we now call the ubiquitin/proteasome pathway.
and to support the proteasome’s substrate unfolding andIn this work, Varshavsky and coworkers exploited their
translocation activities (Figure 1A) (Baumeister et al., 1998;discovery of a temperature-sensitive defect in ubiquitin
Pickart, 2001).conjugation to reveal for the first time the enormous
Much of what is stated in the preceding paragraph
scope of ubiquitin-dependent proteolysis in mammalian
was already known in outline form by the early 1980’s,
cells (Ciechanover et al., 1984; Finley et al., 1984). In
although E1 was the only enzyme that had been thor-
the accompanying supplement, the authors themselves oughly characterized. As shown by Hershko, Rose, and
comment on how their findings influenced the growth coworkers, E1 activates ubiquitin by using ATP to syn-
of the ubiquitin field. Here, I offer an independent per- thesize ubiquitin C-terminal adenylate, which then serves
spective, beginning with the 1984 papers and proceed- as an enzyme bound substrate for the formation of an
ing to some of the developments that, in my view, have E1-ubiquitin thiol ester (Figure 1B) (Haas et al., 1982).
most notably altered our view of ubiquitin from that The latter ubiquitin is passed to an E2 cysteine residue
which prevailed twenty years ago. and from there, in an E3-dependent manner, to the sub-
strate (Figure 1C) (Hershko et al., 1983). Although the
Background: The Ubiquitin/Proteasome Pathway true properties of the proteasome were beyond the
of Protein Degradation wildest imagination of researchers working at that time,
Breaking a peptide bond is a difficult proposition—the it was clear that the ubiquitin-recognizing protease was
uncatalyzed hydrolysis of one bond in a polypeptide a complex, ATP-dependent entity (Hershko et al., 1984b).
chain is estimated to occur with a half-life of several But the most vexing feature of this pathway was the
hundred years under physiological conditions (Wolfenden lack of a biological context. The elegant mechanistic
and Snider, 2001). The kinetic stability of proteins is framework discussed above was developed from exper-
biologically desirable—one wouldn’t want these work- iments conducted in rabbit reticulocyte extracts. De-
horses of the cell to undergo spontaneous fragmenta- spite certain hints (Hershko et al., 1982), it was unclear if
tion—but it creates a problem when proteins need to nucleated mammalian cells harbored the same pathway.
The biological purpose of the pathway was even more
uncertain. Although misfolded and truncated polypep-*Correspondence: cpickart@jhmi.edu
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Figure 1. Components and Mechanisms in
the Ubiquitin/Proteasome Pathway
(A) Overview of pathway showing how ATP is
used in its conjugative (top) and degradative
(bottom) phases. E1, E2, and E3 are ubiquitin
activating, conjugating, and ligase enzymes,
respectively; K denotes a substrate lysine
residue.
(B) E1-catalyzed reaction. Step 1, ubiquitin
adenylate formation; step 2, transfer of ubi-
quitin from adenylate to cysteine (product not
shown); step 3, second round of adenylate
formation to yield fully loaded enzyme.
(C) The ubiquitin conjugation cascade. Elabo-
ration of a polyubiquitin chain (data not
shown) often involves the same E2/E3 com-
plex, but can also involve a different complex
(Hoege et al., 2002). Certain E3 enzymes form
ubiquitin thiol esters during catalysis of sub-
strate ubiquitination (Figure 2 below).
tides were known to be targeted in a selective manner to the nonpermissive temperature (Marunouchi et al.,
for ubiquitination and proteasome degradation (Hershko 1980). Reasoning that this event could be explained by
et al., 1982), no normal protein was yet known to be a failure in ubiquitin conjugation, they set out to evaluate
eliminated by this interesting mechanism. Accordingly, this possibility in a systematic manner.
the pathway was viewed by many as an intracellular In the first republished paper, Finley and coworkers
garbage disposal. This function did not inspire broad show that extracts of ts85 cells grown at a restrictive
interest among biologists. temperature display a marked defect in ubiquitin conju-
One final player needs to be introduced to appreciate gation when compared to extracts of cells grown at a
these classic papers. Histone 2A (H2A) was the first permissive temperature (Finley et al., 1984). Neither the
protein shown to be modified by ubiquitin through an parental cells nor temperature-insensitive revertant cells
isopeptide linkage (Goldknopf et al., 1975). It is the most (both of which had normal cell cycles) displayed this
abundant ubiquitinated protein in most nucleated mam- property, indicating that inhibition of ubiquitination is
malian cells, comprising 10%–20% of the total conju- tightly correlated with the defect in cell cycle progres-
gate pool; histone H2B is also subject to ubiquitination sion. Inhibition was similar in assays of ubiquitin conju-
(Jason et al., 2002). Because H2A is a long-lived protein, gation to lysozyme (a model substrate recognized by
its status as a natural substrate of ubiquitination shed an E3 enzyme in the extract), unidentified cellular pro-
no direct light on the purposes of ubiquitin-dependent teins, and H2B (Ciechanover et al., 1984; Finley et al.,
proteolysis. Nonetheless, ubiquitinated H2A played an 1984). Knowing as we do today that there are diverse
important part in the work discussed below. substrate-specific E3s, the global character of the ob-
served defect affords virtual proof that the failure occurs
at an early step in the conjugation cascade. To provets85 Cells, Ubiquitination, and Proteolysis
that the very first enzyme was the labile factor, the re-The mouse mammary carcinoma cell line called ts85
searchers affinity-purified E1. They found that the homo-was discovered based on its phenotype of temperature-
geneous enzyme from ts85 cells, but not E1 from thesensitive arrest in the G2 phase of the cell cycle, but
parental cells, rapidly lost ubiquitin-activating capacitythe molecular basis of this interesting phenotype was
at high temperature as measured in assays of ubiquitinunknown (Mita et al., 1980). Varshavsky and coworkers
thiol ester formation (Finley et al., 1984). The activitywere intrigued by the rapid disappearance of ubiquiti-
nated H2A that occurred when ts85 cells were shifted of E1 disappeared with similar kinetics to activity in
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ubiquitin-substrate conjugation (Ciechanover et al., the later discovery that the turnover of mitotic cyclins
is ubiquitin-dependent (Glotzer et al., 1991; Hershko et1984; Finley et al., 1984), further supporting a causal
al., 1991). The recognition that the ubiquitin/proteasomerelationship between the two defects and suggesting
pathway plays a central role in cell cycle progressionthat inactivation of E1 underlies temperature-sensitive
led to a series of key findings that proved to be relevantcell cycle arrest. Years later, with the advent of routine
not only for this function, but also more generally. IncDNA cloning, it was shown that the defect in cell cycle
particular, the defining member of a large family of multi-progression is indeed rescued following transfection of
subunit E3s, called SCF complexes (Skp/Cullin/F box),a wild-type E1 cDNA (Ayusawa et al., 1992).
was discovered through investigations of how ubiquitin-Recognizing that this conditional defect in ubiquitin
dependent proteolysis regulates the G1/S transitionconjugation could be exploited for purposes of func-
(Feldman et al., 1997; Skowyra et al., 1997). Another,tional discovery, Ciechanover and coworkers asked a
distantly related E3, called the APC (Anaphase Promot-simple question: how are rates of intracellular proteo-
ing Complex), regulates the metaphase-to-anaphaselysis affected when the activity of the ubiquitin/pro-
transition and exit from mitosis (reviewed in Jackson etteasome pathway is drastically reduced through the
al., 2000; Peters, 2002). The substrates targeted by thesethermal inactivation of E1? Pulse-chase experiments re-
ligases are activators and inhibitors of cyclin-dependentvealed that the turnover of abnormal or truncated poly-
kinases (CDKs). The role of the ubiquitin/proteasomepeptides was inhibited by more than 80% when ts85
pathway in regulating cell cycle progression is reviewedcells were shifted to the restrictive temperature, con-
in detail elsewhere in this issue (Murray, 2004 [this issuecomitant with a profound inhibition of the ubiquitination
of Cell]). Studies of SCF substrate susceptibility to ubi-of these polypeptides (Ciechanover et al., 1984). This
quitin tagging also provided the first, and still someoutcome agreed with earlier indications that misfolded
of the most notable, examples of how phosphorylationproteins are selectively recognized for ubiquitin tagging
regulates E3/substrate interactions, as discussed in the(Hershko et al., 1982), but it provided a decisive demon-
article by Murray and in excellent earlier reviews (De-stration that the ubiquitination of these species in nucle-
shaies and Ferrell, 2001; Jackson et al., 2000; Peters,ated cells correlates with their degradation. In the most
2002).important experiment, the turnover of short-lived normal
Somewhat ironically, this first genetic experiment inproteins was found to be inhibited by more than 90%
the ubiquitin/proteasome field involved mammalianat the restrictive temperature. The turnover of these
cells (Ciechanover et al., 1984; Finley et al., 1984). How-polypeptides at the permissive temperature was accom-
ever, the same year saw the cloning of the first ubiquitinpanied by their transient appearance in the ubiquitin
pathway gene in S. cerevisiae (Ozkaynak et al., 1984),conjugate pool, and was ATP-dependent but insensitive
ushering in a long period in which budding yeast domi-to lysosomotropic agents—all as expected for turnover
nated molecular genetic investigations of ubiquitin-in the ubiquitin/proteasome pathway. (The identification
dependent signaling. Not only have these investigationsof the proteasome as the relevant protease did not occur
illuminated these processes; they have also generatedfor several more years, however.)
powerful tools in the form of plasmids and yeast strains
(Hochstrasser, 1996). Nonetheless, mammalian cell lines
Enduring Lessons
like ts85 remain useful today because in contrast to
Data published in these papers represented the first
the situation with proteasomes, there are still no cell-
evidence that the ubiquitin/proteasome pathway is the permeable inhibitors of ubiquitination. Even though a
principal mechanism for turnover of normal short-lived thermolabile E1 enzyme is a rather blunt instrument,
proteins in mammalian cells. Subsequent research has cells harboring it can be used to show that a given event
confirmed this conclusion in several different ways. For relies on ubiquitin conjugation. Such cell lines have fig-
example, cell-permeable inhibitors of the proteasome ured importantly in studies of ubiquitin-dependent pro-
ablate the turnover of short-lived proteins in mammalian cesses that are proteasome-independent (discussed
cells (Rock et al., 1994) and mutations in (yeast) protea- below), including endocytosis and protein trafficking (for
some subunit genes elicit a similar effect, in some cases example, Strous et al., 1996). These cell lines have also
concomitant with cell cycle arrest (Ghislain et al., 1993; proved useful for demonstrating the ubiquitin indepen-
Gordon et al., 1993; Heinemeyer et al., 1991; Seufert and dence of other events (Shringarpure et al., 2003).
Jentsch, 1992). Confirming an important role of ubiquitin Do the 1984 papers hold any surprises for today’s
conjugation, deletion of the UBC4 and UBC5 E2 genes reader? There was at least one for the author. Finley et
of Saccharomyces cerevisiae greatly inhibits the turn- al. combined equal volumes and parental and ts85 cell
over of short-lived and abnormal proteins (Seufert and extracts and found that the mixture displayed 50% of
Jentsch, 1990). These two E2s act in concert with many the parental extract’s ubiquitination activity at several
E3s; in this respect they resemble E1, which provides temperatures (Finley et al., 1984). The authors argued
activated ubiquitin for all conjugation processes. (In that if the heat-labile component had been a regulatory
most cases, the deletion of E2-encoding genes elicits factor such as a kinase, the active factor in the parental
rather selective effects because of the pronounced extract should have acted catalytically on its targets in
specificities of E3s, as discussed below.) the ts85 extract and complemented the ubiquitination
The studies of Varshavsky and coworkers also pro- defect (Finley et al., 1984). In fact, from today’s point of
vided the first clue that ubiquitination regulates the cell view it is rather surprising that the active E1 in the paren-
cycle. The argument that proteolysis is the ubiquitin- tal extract did not produce exactly this outcome. E1
dependent process that underlies this regulation, al- is a far more efficient enzyme than most downstream
conjugating factors and is often considered to affordthough inferential in 1984, was decisively validated by
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ubiquitin activation activity in excess of that required 2000; Pickart, 2001). From a mechanistic standpoint,
E3s fall into two groups: those that utilize a covalentby subsequent reactions (Pickart, 2001). The result ob-
tained by Finley et al. therefore raises the possibility mechanism (HECT domain E3s) and those that do not
(most notably RING-domain E3s) (Figure 2). The mam-that in contrast to current views, the E1 step could be
rate-limiting for certain ubiquitination events. malian RING-domain family is very large and it is likely
that a substantial fraction of its members are E3s. Some
consist of just one (multidomain) subunit (Lorick et al.,Then and Now
1999), whereas others are multiprotein complexes inThe two papers discussed above led to a new world-
which each subunit is a member of a distinct proteinview; not only was the ubiquitin/proteasome pathway a
family, with the (small) RING subunit acting to recruitmajor proteolytic mechanism in the average mammalian
the E2 (Seol et al., 1999) (see also below). There arecell, but it was also likely to regulate cell cycle progres-
approximately fifty E2s and more than seventy deubiqui-sion. These conclusions are so well accepted today that
tinating enzymes in humans, while the 26S proteasomeit is difficult to appreciate the magnitude of their impact
is composed of at least 64 protein subunits, which areat the time the two papers appeared. Succinctly put,
encoded by 32 independent genes (Baumeister et al.,this work forced biologists as well as biochemists to
1998). (This review largely ignores the fascinating topicrespect the ubiquitin/proteasome pathway.
of proteasomes.) Altogether, several percent of the hu-In what other ways has our view of ubiquitination
man genome is likely to be devoted to the ubiquitinchanged since 1984? A comprehensive discussion
pathway, taking into account both proteolytic and non-would greatly exceed the scope of this article but a few
proteolytic functions (Semple, 2003). In 1984, even thedevelopments are noteworthy, especially when viewed
most ardent ubiquitin supporter would have rejected thisthrough the lens of the state of knowledge in 1984.
number, which also applies in plants and yeast (Semple,
2003; Vierstra, 2003).Ubiquitination Regulates Lysosomal Proteolysis
Any perspective on the ubiquitin/proteasome path-Researchers studying ubiquitin in the mid-1980’s held it
way must remark on the hierarchical nature and regula-as a tenet of faith that the ubiquitin/proteasome pathway
tory potential afforded by this multiplicity of conjugationhad no point of intersection with lysosomal proteolysis.
factors. Each E3 enzyme recognizes a restricted set ofThis commandment reflected the fact that agents which
substrates (discussed below) and is served by one or adisrupt lysosomal functioning, have no effect on the
few E2s. These properties are a reflection of the modularATP-dependent turnover of short-lived and abnormal
construction of E3s—the substrate and the E2 enzymeproteins (see Ciechanover et al., 1984). In direct contra-
bind to separate sites, with members of a given E3 familydiction of this formerly strict rule, we now know that
sharing a conserved E2 binding domain. Originally in-ubiquitination is sometimes required for lysosomal pro-
ferred from functional studies, these molecular proper-teolysis. This could not be detected in the 1984 study
ties are now documented by atomic-resolution struc-because only a small fraction of short-lived proteins is
tures of E3s complexed with their cognate E2s (Brzovictargeted to lysosomes. However, later studies of individ-
et al., 2003; Huang et al., 1999; Zheng et al., 2000) andual endocytosed proteins revealed that a subset of these
substrates (discussed below).molecules must be conjugated to ubiquitin as a trigger
Dedicated substrate/E3 pairings permit independentfor internalization from the plasma membrane (Hicke
regulation of the ubiquitination of distinct substrates. Inand Riezman, 1996; Kolling and Hollenberg, 1994). In
some cases, E3 specificity may be further modulatedfact, endocytosis is just one of many protein trafficking
through the association of one E3 with different E2ssteps that depend on ubiquitin conjugation, as recently
(Chen et al., 1993). Having many E2s might also controlreviewed elsewhere (Aguilar and Wendland, 2003; Hicke
the flow of activated ubiquitin to the cognate E3s ofand Dunn, 2003). The discovery that retroviruses subvert
different E2s. This mechanism, if operative, would becertain ubiquitin-dependent trafficking events in order
most important if the activity of E1 is limiting. Finally,to achieve budding offers exciting new possibilities for
certain RING-domain E3 families take the modular con-therapeutic intervention (Garrus et al., 2001).
struction idea to an extreme. As first shown for the SCF
E3s in the context of cell cycle regulation, the E2- andTruly, a System
substrate binding functions can be delegated to sepa-If a ubiquitin researcher placed in cryostorage in 1984
rate polypeptides, which are brought together throughwere to be thawed out today, there is little doubt about
adaptor-dependent interactions with a scaffold proteinwhat he or she would find most remarkable: the com-
called a cullin (Bai et al., 1996; Feldman et al., 1997;plexity of it all. In the mid-1980’s, we knew of one E1,
Skowyra et al., 1997). The existence of substrate bindingseveral E2s, and one E3 (Hershko et al., 1983). Although
(F boxes; SOCs boxes), cullin, and adaptor protein fami-this collection of enzymes already seemed too small to
lies (Skps, Elongins), in conjunction with functional data,account for the burgeoning biology, no one could have
shows that E3 specificity can be reprogrammed bypredicted the system’s actual breadth. Several factors
changing the identity of the substrate recognition sub-have combined to produce this knowledge, including
unit (Deshaies, 1999).detailed investigations of specific ubiquitination/turn-
over events, newly identified associations with human
disease, genome sequencing projects, and bioinformat- Substrate Selection and Its Regulation
The finding that most short-lived proteins are degradedics. The recognition that E3s are organized into a small
number of families was particularly important (Deshaies, in the ubiquitin/proteasome pathway (Ciechanover et
al., 1984) raised a pressing question about specificity.1999; Jackson et al., 2000; Joazeiro and Weissman,
Review
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Figure 2. Major E3 Classes
(A) HECT domain E3s (Homologous to E6AP
C-Terminus) bind cognate E2s via the con-
served HECT domain and transiently accept
ubiquitin at a cysteine residue in this region;
a different region of the same polypeptide
chain binds the substrate (blue) through an
element in the degron (square).
(B) RING-domain E3s (Really Interesting New
Gene) are scaffold proteins that use the RING
domain (red) to bind the E2 and a different
domain (orange) to bind the substrate. In SCF
and other multisubunit RING-domain E3s, the
RING and substrate binding domains occur
in separate polypeptides (text).
Did all such substrates share a common recognition 1998), whereas other E3s coopt chaperones as their
specificity factors (Cyr et al., 2002), but it is uncertaindeterminant? This was unlikely a priori. The existence
of many E3s solves this problem in principle, but fails to if these targeting mechanisms are the whole story. A
burgeoning area of research suggests that inadequateshow how selective recognition is practiced. Elucidating
E3/substrate interactions has been an enduring goal of clearance of misfolded proteins by the ubiquitin/protea-
some pathway may contribute to neurodegenerativeresearchers over the last two decades.
The first E3 to be characterized was the one that diseases such as Parkinson’s and Huntington’s, giving
new impetus to studies of misfolded protein degradationrecognized the denatured lysozyme substrate used in
early biochemical studies. Called E3, it seemed to re- (Berke and Paulson, 2003; Giasson and Lee, 2003).
Studies of degron recognition in physiological sub-quire that model substrates carry a free -amino group
(Hershko et al., 1984a). In 1986, studies by Varshavsky strates have revealed a level of regulatory sophistication
that would have been unimaginable in 1984. E3/degronand coworkers in yeast unexpectedly uncovered the
complete relationship between the identity of the interactions can be modulated by posttranslational modi-
fications (among other mechanisms) that serves to linkN-terminal amino acid and substrate stability, called the
N-end rule (Bachmair et al., 1986). Further investigations ubiquitination to other cellular events (reviewed in De-
shaies, 1999; Deshaies and Ferrell, 2001; Laney and Hoch-of this mechanism showed that the orthologous yeast
E3 (Ubr1) recognized this determinant, which together strasser, 1999; Peters, 2002) (Figure 3). Most famously,
CDK-catalyzed phosphorylation triggers the proteolysiswith a lysine residue subject to ubiquitination, was
termed an N-degron (Varshavsky, 1997). These studies of CDK regulators at appropriate points in the cell cycle
(see Deshaies and Ferrell, 2001; Peters, 2002 and Mur-provided the functional definition of a degron (an ele-
ment that is both necessary and sufficient for substrate ray, 2004 [this issue of Cell]). Another recent example
is the oxygen-dependent hydroxylation of a specific pro-ubiquitination) and established the modular organiza-
tion that ultimately proved to apply to all E3s. The N-end line residue in Hypoxia Inducible Factor-1 (HIF-1),
which triggers recognition by a cullin-based E3 that hasrule is also biologically important, as dramatically shown
by the essentiality of one of its components for cardio- the Von Hippel Lindau (VHL) tumor suppressor protein
as its specificity subunit; the ensuing degradation ofvascular development in the mouse (Kwon et al., 2002).
New degrons continue to be reported at a regular rate. HIF-1 shuts off a hypoxic program of gene expression
(Ivan et al., 2001; Jaakkola et al., 2001). Structural stud-In one interesting recent example, the specificity subunit
of a cytosolic SCF E3 was found to recognize N-linked ies of this E3 show that the hydroxyproline residue of
HIF-1 binds to a region of VHL that is frequently mu-high-mannose oligosaccharides (Yoshida et al., 2002).
(In a turn of events that would amaze the time-traveling tated in a hereditary cancer syndrome (Hon et al., 2002;
Min et al., 2002; Stebbins et al., 1999).researcher mentioned above, it was discovered in the
1990’s that misfolded proteins of the endoplasmic retic-
ulum (ER) are ejected from that compartment and de- Structurally Distinct Ubiquitin Modifications
Impart Diversity in Signalinggraded by the cytosolic ubiquitin/proteasome pathway
in a process known as ERAD (ER-Associated Degrada- In 1984 we knew that histones could be modified with
a single ubiquitin. Although the purpose of this modifica-tion) (Kostova and Wolf, 2003). Since proteins can only
acquire these sugars in the ER interior, having the glycan tion was mysterious, it definitely did not signal proteoly-
sis. Substrates destined for proteasomes, on the otheras a component of the degron may be a clever way
to achieve uniform targeting of a subset of proteins hand, were decorated with many ubiquitins and this high
stoichiometry seemed to be important for productiveoriginating in that compartment. Surprisingly, however,
we still do not fully understand the one example of selec- degradation (Chin et al., 1982; Hershko et al., 1984b;
Hough and Rechsteiner, 1986). Later work proved thattive targeting that was known in 1984, namely that of
misfolded polypeptides. Certain E3s recognize inappro- these multiple ubiquitins must be linked together in a
specific type of polyubiquitin chain to order to guaranteepriately exposed hydrophobic surfaces (Johnson et al.,
Cell
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Figure 3. Mechanisms for Modulating Sub-
strate Recognition by E3s
Shown are posttranslational modifications
and other mechanisms known to regulate the
recognition of cognate substrates by differ-
ent E3s. For discussions of phosphorylation-
based recognition, see Deshaies, 1999; Jack-
son et al., 2000; Joazeiro and Weissman,
2000; Murray, 2004; for deacetylation, see
Brooks and Gu, 2003; for aminoacylation, see
Kwon et al., 2002; Varshavsky, 1997; for oxi-
dation, see Kwon et al., 2002; for other exam-
ples, see the text.
efficient targeting to proteasomes (Chau et al., 1989; ubiquitin chains remain to be discovered (Peng et al.,
2003).Finley et al., 1994). In contrast, ubiquitin-dependent pro-
tein trafficking usually requires the ligation of just one
ubiquitin to the substrate (Gregory et al., 2003; Hicke
and Dunn, 2003). Thus, mono- and polyubiquitination Parallel Universes
From structurally distinct ubiquitin modifications, it isare associated with different functional outcomes.
A different type of polyubiquitin chain, linked through only a small step to a remarkable recent develop-
ment—structurally distinct ubiquitins (so to speak). Weubiquitin-K63 instead of K48, is generated during the
autoubiquitination of TRAF family signal-transducing now know that ubiquitin defines a family of structurally
related signaling proteins which share a common bio-E3s, apparently leading to the activation of a specific
cytosolic kinase and ultimately to the expression of chemical mechanism of isopeptide tagging. The inter-
feron-induced ISG15 protein was the first such proteinNF-B target genes in mammals (Deng et al., 2000; Ko-
valenko et al., 2003; Trompouki et al., 2003; Wang et to be discovered (Loeb and Haas, 1992); other examples
followed in short order. The functional range of individualal., 2001). The same type of atypical chain regulates
ribosome function in the cytosol (Spence et al., 2000) family members varies widely, as reviewed elsewhere
(Muller et al., 2001; Schwartz and Hochstrasser, 2003).and is necessary for a conserved pathway of DNA dam-
age tolerance in the nucleus (Hofmann and Pickart, Nedd8/Rub1, for example, seems to function only as an
activator of cullin-based E3s, whereas SUMO modifies1999; Spence et al., 1995). Exactly how these noncanoni-
cal polyubiquitin chains signal downstream events is numerous cellular proteins and may signal several differ-
ent fates for its substrates.unclear, but they do not evoke substrate proteolysis.
They could be recruitment signals for unidentified fac-
tors or they might modulate the properties of the target
protein to which they are attached. Still, their properties Histone Ubiquitination: Somewhat
Less Mysteriousindicate that different polyubiquitin chains can be asso-
ciated with distinct signaling outcomes. Indeed, ubiqui- Why are histones subject to ubiquitination? Studies con-
ducted between 1984 and 2000 suggested several pos-tin-dependent DNA damage tolerance presents a re-
markable example of how signal structure can regulate sible answers, none of which appeared to be definitive,
probably because the modification can serve severaldownstream effects. Depending on the circumstances,
the DNA polymerase processivity factor PCNA is modi- functions (Jason et al., 2002). A recent advance came
from work in budding yeast, which revealed that site-fied at a single site by monoubiquitin, a K63-linked poly-
ubiquitin chain, or the ubiquitin-like protein SUMO specific ubiquitination of histone H2B promotes site-
specific methylation of histone H3, with an ultimate read-(Hoege et al., 2002). The chain signals error-free replica-
tive bypass of DNA lesions (Hoege et al., 2002), whereas out of transcriptional silencing (Sun and Allis, 2002).
This is only one of several newly discovered roles formonoubiquitin and SUMO may signal bypass by distinct
translesion polymerases (Stelter and Ulrich, 2003). ubiquitination in transcriptional regulation (Conaway et
al., 2002).Being a protein, ubiquitin offers its downstream sig-
nal-transducing components more abundant and so-
phisticated recognition opportunities than are afforded
by conventional covalent modifiers; polymerization fur- Forward to the Future
Although many features of ubiquitin biology stand inther expands these possibilities. This mechanism is not
unique to ubiquitin. Oligo- and polysaccharides richly clearer relief today than in 1984, the intensity of effort
focused on the pathway has also served to spotlightembody the principle of structure-based recognition
and polyphosphate chains have unique signaling prop- features that we do not yet (or still do not) understand.
Because a full discussion of these interesting questionserties (Wang et al., 2003). The recent detection of all
seven possible ubiquitin-ubiquitin linkages in the yeast would require a separate review, only a few are men-
tioned here.proteome suggests that new signaling functions of poly-
Review
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Deubiquitination: The End at the Beginning Ubiquitination and Human Disease
An increasing number of inherited diseases has beenWhile there is a clear rationale for having many E2s
and E3s, we still lack a satisfactory explanation for the found to be caused dysfunctions in ubiquitination, offer-
ing a challenge for the present and an opportunity formultiplicity of deubiquitinating enzymes. Many of these
enzymes belong to a large cysteine protease family, the the future. Typically, a mutation in an E3 enzyme or
its cognate substrate results in substrate stabilization,Ubiquitin processing Proteases (Amerik et al., 2000). A
few UBPs play important roles in regenerating ubiquitin leading to deleterious consequences. Stabilization of
HIF-1 by mutations in VHL (see above) may conformfrom proteolytic intermediates (providing the fodder for
new ubiquitination events) and another handful have to this paradigm. The inappropriate destabilization of a
cellular protein can also be a pathologic event (Scheffnerbeen implicated in a specific biological process (Amerik
et al., 2000). But most of them are functionally uncharac- et al., 1990). These are just two examples among many,
as recently reviewed elsewhere (Schwartz and Ciechan-terized. One attractive hypothesis proposes that certain
UBPs are target-protein specific, but so far only a few over, 1999). Unfortunately, matching an interesting E3
with its cognate substrate (or vice versa) is often a diffi-enzymes definitively conform to this paradigm (Cohen
et al., 2003; Li et al., 2002). Meanwhile, additional families cult proposition (Giasson and Lee, 2003; Huang et al.,
1999). The same difficulty applies in the analysis of de-of deubiquitinating enzymes continue to be discovered.
A small zinc-dependent family (JAMM/MPN) includes ubiquitination, dysfunctions of which occur in several
known diseases (see above). In contrast to the biochem-a proteasome subunit that removes polyubiquitin chains
from substrates during proteolysis (Verma et al., 2002; ical fractionation approaches that predominated in
1984, enzyme/substrate matching today is frequentlyYao and Cohen, 2002). A much larger cysteine protease
family (OTU) includes a known negative regulator of the achieved by protein interaction screening. New technol-
ogies, including RNA interference, are also being de-inflammatory response (Balakirev et al., 2003). However,
it was CYLD, a member of the UBP family that is also ployed in the service of this goal (for example, Brummel-
kamp et al., 2003). Finally, global inhibition of thea tumor suppressor, that was recently shown to repress
NF-B activation, possibly by removing K63-linked poly- ubiquitin-proteasome pathway may be an exacerbating
factor in certain diseases (Bence et al., 2001; Berke andubiquitin chains from TRAF E3s (Kovalenko et al., 2003;
Trompouki et al., 2003). Paulson, 2003; Song et al., 2003), but in other cases it
can have a therapeutically beneficial effect. An active
site inhibitor of the proteasome was recently approved
for treatment of multiple myeloma and is being testedHow Do E3s Work?
In the prevailing view, RING-type E3 enzymes are bridg- for efficacy against other cancers (Adams, 2002). Ulti-
mately, E3 enzymes that regulate cell cycle progressioning factors that bring the E2 enzyme with its activated
ubiquitin into the vicinity of the substrate, and then hope and cell proliferation may provide important new thera-
peutic targets in cancer and other diseases (Nalepa andfor the best. However, while induced proximity can pro-
vide large catalytic rate enhancements, such effects re- Harper, 2003).
quire an exact placement of the reactants (Fersht, 1984).
It is unclear that E3s can meet this requirement, given Acknowledgments
the tens of angstroms that are inferred to separate the
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be cited due to space limitations. I am grateful to R. Cohen and M.crystal structures (Orlicky et al., 2003; Zheng et al., 2002).
Hochstrasser for critical commentary on the manuscript. Work in
Although the E2 enzyme provides catalytic assistance my laboratory is supported by NIH grants DK46984 and GM60372.
to RING E3s (Wu et al., 2003), additional mechanisms
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